Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

被引:158
|
作者
Przedborski, S
Chen, QP
Vila, M
Giasson, BI
Djaldatti, R
Vukosavic, S
Souza, JM
Jackson-Lewis, V
Lee, VMY
Ischiropoulos, H
机构
[1] Columbia Univ, Dept Neurol, Neurosci Res Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[5] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
dopaminergic neurons; MPTP; neurodegeneration; Parkinson's disease; substantia nigra; synuclein;
D O I
10.1046/j.1471-4159.2001.00174.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural and functional alterations of alpha -synuclein is a presumed culprit in the demise of dopaminergic neurons in Parkinson's disease (PD), alpha -Synuclein mutations are found in familial but not in sporadic PD, raising the hypothesis that effects similar to those of familial PD-linked alpha -synuclein mutations may be achieved by oxidative post-translational modifications. Here, we show that wild-type alpha -synuclein is a selective target for nitration following peroxynitrite exposure of stably transfected HEK293 cells. Nitration of alpha -synuclein also occurs in the mouse striatum and Ventral midbrain following administration of the parkinsonian neurotoxin 1-methyt-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Conversely, beta -synuclein and synaptophysin were not nitrated in MPTP-intoxicated mice. Our data demonstrate that alpha -synuclein is a target for tyrosine nitration, which, by disrupting its biophysical properties, may be relevant to the putative role of alpha -synuclein in the neurodegeneration associated with MPTP toxicity and with PD.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 50 条
  • [11] Thrapeutic effect of Mirtazapine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model for Parkinson's disease
    Kasahara, Jiro
    Kadoguchi, Naoto
    Okabe, Shinji
    Yamamura, Yukio
    Yokoyama, Hironori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 95P - 95P
  • [12] Neuroprotective effect of Pioglitazone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model for Parkinson's disease
    Kasahara, Jiro
    Tsukada, Tatsuya
    Kuroiwa, Hayato
    Okabe, Shinji
    Fukano, Tatsuya
    Uchida, Hiroto
    Yokoyama, Hironori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 114P - 114P
  • [13] Therapeutic effect of zonisamide on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-treated mice model of Parkinson's disease
    Yokoyama, Hironori
    Yano, Ryohei
    Kato, Hiroyuki
    Araki, Tsutomu
    Kasahara, Jiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 115P - 115P
  • [14] Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Han, Bing
    Che, Xin
    Zhao, Yue
    Li, Cuiting
    He, Jie
    Lu, Yan
    Wang, Zhenhua
    Wang, Tian
    BEHAVIOURAL PHARMACOLOGY, 2019, 30 (01): : 36 - 44
  • [15] NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Wu, DC
    Teismann, P
    Tieu, K
    Vila, M
    Jackson-Lewis, V
    Ischiropoulos, H
    Przedborski, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 6145 - 6150
  • [16] Cyclohexylbisphenol inhibits oxidative stress in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson's
    Chalimoniuk, M
    Liu, Y
    Kopczuk, D
    Strosznajder, J
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 93 - 93
  • [17] Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson's Disease Mouse Model
    Zhang, Zijuan
    Li, Hai
    Su, Yunfang
    Ma, Jinlian
    Yuan, Ye
    Yu, Ziyang
    Shi, Ming
    Shao, Simai
    Zhang, Zhenqiang
    Holscher, Christian
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [18] Alteration of clock gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
    Hayashi, Akane
    Matsunaga, Naoya
    Ikeda, Eriko
    Koyanagi, Satoru
    Ohdo, Shigehiro
    NEUROSCIENCE RESEARCH, 2010, 68 : E81 - E82
  • [19] Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Peng, Jun
    Andersen, Julie K.
    AGING CELL, 2011, 10 (02): : 255 - 262
  • [20] NEUROPROTECTIVE EFFECTS OF LIXISENATIDE AND LIRAGLUTIDE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
    Liu, W.
    Jalewa, J.
    Sharma, M.
    Li, G.
    Li, L.
    Hoelscher, C.
    NEUROSCIENCE, 2015, 303 : 42 - 50